International Business Machines Corp. (IBM) stock edged higher in Tuesday's premarket session, even as broader markets turned cautious. Nasdaq futures fell 1.05%, and S&P 500 futures slipped 0.15%, but IBM shares managed a 1.46% gain to $303.91.

Investors are focusing on IBM's strong technical setup after a sharp rally over the past several months. The stock remains well above key moving averages, reinforcing the long-term bullish trend. But with shares trading near record highs, the recent advance could also invite some profit-taking.

New Mainframe Configurations to Ease Data Center Constraints

Separately, IBM on Tuesday introduced new IBM z17 and IBM LinuxONE 5 configurations, adding rack-mount and single-frame options across its entire Z and LinuxONE portfolio for the first time. The new systems are designed to help enterprises optimize data center space, improve deployment flexibility, and support AI workloads.

IBM said the configurations support up to 82 cores and 18 TB of memory, while the z17 ME2 delivers up to 10% greater throughput per core than the IBM z16 A02, depending on workload and configuration. The company also unveiled new software, including Infrastructure Management for IBM Z and LinuxONE, IBM COBOL Elevate for z/OS, and Crypto Discovery & Inventory capabilities to simplify infrastructure management, modernization, and post-quantum security.

"The number of mission-critical workloads is rising at an incredible pace," said Tom McPherson, general manager of IBM Z and LinuxONE. "With these new IBM Z and IBM LinuxONE systems, we're making it easier to run workloads where they make the most sense."

The new IBM z17 systems, IBM LinuxONE Rockhopper 5, and IBM LinuxONE 5 Express are scheduled to become generally available on Aug. 12, while IBM Infrastructure Management for IBM Z and IBM LinuxONE will be available Aug. 14. IBM COBOL Elevate for z/OS is expected to launch Sept. 18.

Technical Analysis: Strong Uptrend, But Watch the Death Cross

IBM remains in a strong long-term uptrend. The stock is trading 11.2% above its 20-day simple moving average of $272.90 and 10.6% above its 200-day SMA of $274.49. It also sits 18.4% above its 50-day SMA of $256.30 and 20.4% above its 100-day SMA of $252.21, reflecting sustained buying momentum.

Momentum indicators also remain constructive. The MACD is above its signal line, while the histogram remains positive, suggesting buying momentum continues to strengthen.

One longer-term technical caution remains: IBM formed a death cross in March, when the 50-day SMA fell below the 200-day SMA. Although the stock has since rebounded strongly, some traders still view that signal as a reminder that longer-term trend risks can persist.

The stock reached a 52-week high of $332.46 in June. That area now represents the next major resistance level. Initial support sits near $243.50, where buyers previously stepped in.

Earnings and Analyst Outlook

Investors are looking ahead to IBM's next earnings report, scheduled for July 22. Wall Street expects earnings of $3.02 per share, up from $2.80 a year earlier, on revenue of $17.86 billion compared with $16.98 billion in the prior-year period.

The stock carries a consensus Buy rating with an average analyst price forecast of $300.71. Recent analyst actions include:

• Bank of America Securities reiterated Buy and raised its price forecast to $330 on July 6.
• Morgan Stanley maintained Equal-Weight and raised its price forecast to $267 on June 23.
• JPMorgan upgraded IBM to Overweight and raised its price forecast to $291 on June 23.

Quality Score High, But Value Weak

Market data rates IBM highly for quality, with a score of 85.77, while momentum (46.06) and growth (59.64) remain neutral. Value scores weaker at 24.27, suggesting much of the company's positive outlook may already be reflected in the share price.

Overall, IBM's profile continues to be supported by strong business quality and a favorable long-term trend, although the recent rally may limit near-term upside without another catalyst.

Top ETF Exposure

IBM represents one of the largest holdings in the First Trust NASDAQ Technology Dividend Index Fund (TDIV) and the FT Vest Technology Dividend Target Income ETF (TDVI), each with a 6.97% weighting. It also accounts for 4.57% of the Invesco Dow Jones Industrial Average Dividend ETF (DJD). Because of IBM's sizable weight in these funds, large ETF inflows or outflows can influence demand for the stock.

Price Action

IBM shares were trading up 1.46% at $303.91 during premarket trading on Tuesday, according to market data.